Literature DB >> 18560437

D-amino acid oxidase activity and expression are increased in schizophrenia.

P W J Burnet, S L Eastwood, G C Bristow, B R Godlewska, P Sikka, M Walker, P J Harrison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18560437      PMCID： PMC2629619          DOI： 10.1038/mp.2008.47

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  9 in total

Review 1.  Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia.

Authors:  M P M Boks; T Rietkerk; M H van de Beek; I E Sommer; T J de Koning; R S Kahn
Journal:  Eur Neuropsychopharmacol       Date:  2007-01-23       Impact factor: 4.600

Review 2.  Glycine transport inhibitors and the treatment of schizophrenia.

Authors:  Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2008-01-01       Impact factor: 13.382

Review 3.  Glutamatergic mechanisms in schizophrenia.

Authors:  Guochuan Tsai; Joseph T Coyle
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

4.  Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).

Authors:  Ranjna Kapoor; Kelly Sy Lim; Alice Cheng; Therese Garrick; Vimal Kapoor
Journal:  Brain Res       Date:  2006-07-07       Impact factor: 3.252

5.  D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor.

Authors:  J P Mothet; A T Parent; H Wolosker; R O Brady; D J Linden; C D Ferris; M A Rogawski; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

6.  A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia.

Authors:  Inna Bendikov; Carmit Nadri; Shirly Amar; Rogerio Panizzutti; Joari De Miranda; Herman Wolosker; Galila Agam
Journal:  Schizophr Res       Date:  2006-12-06       Impact factor: 4.939

7.  Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.

Authors:  Ilya Chumakov; Marta Blumenfeld; Oxana Guerassimenko; Laurent Cavarec; Marta Palicio; Hadi Abderrahim; Lydie Bougueleret; Caroline Barry; Hiroaki Tanaka; Philippe La Rosa; Anne Puech; Nadia Tahri; Annick Cohen-Akenine; Sylvain Delabrosse; Sébastien Lissarrague; Françoise-Pascaline Picard; Karelle Maurice; Laurent Essioux; Philippe Millasseau; Pascale Grel; Virginie Debailleul; Anne-Marie Simon; Dominique Caterina; Isabelle Dufaure; Kattayoun Malekzadeh; Maria Belova; Jian-Jian Luan; Michel Bouillot; Jean-Luc Sambucy; Gwenael Primas; Martial Saumier; Nadia Boubkiri; Sandrine Martin-Saumier; Myriam Nasroune; Hélène Peixoto; Arnaud Delaye; Virginie Pinchot; Mariam Bastucci; Sophie Guillou; Magali Chevillon; Ricardo Sainz-Fuertes; Said Meguenni; Joan Aurich-Costa; Dorra Cherif; Anne Gimalac; Cornelia Van Duijn; Denis Gauvreau; Gail Ouellette; Isabel Fortier; John Raelson; Tatiana Sherbatich; Nadejda Riazanskaia; Evgeny Rogaev; Peter Raeymaekers; Jeroen Aerssens; Frank Konings; Walter Luyten; Fabio Macciardi; Pak C Sham; Richard E Straub; Daniel R Weinberger; Nadine Cohen; Daniel Cohen; Gail Ouelette; John Realson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-03       Impact factor: 11.205

8.  In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

Authors:  Tiziana Adage; Anne-Cécile Trillat; Anna Quattropani; Dominique Perrin; Laurent Cavarec; Jeffrey Shaw; Oxana Guerassimenko; Claudio Giachetti; Béatrice Gréco; Ilya Chumakov; Serge Halazy; Arthur Roach; Paola Zaratin
Journal:  Eur Neuropsychopharmacol       Date:  2007-08-02       Impact factor: 4.600

9.  d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia.

Authors:  Louise Verrall; Mary Walker; Nancy Rawlings; Isabel Benzel; James N C Kew; Paul J Harrison; Philip W J Burnet
Journal:  Eur J Neurosci       Date:  2007-09       Impact factor: 3.386
  9 in total
  43 in total

Review 1.  Genetic neuropathology of schizophrenia: new approaches to an old question and new uses for postmortem human brains.

Authors:  Joel E Kleinman; Amanda J Law; Barbara K Lipska; Thomas M Hyde; Justin K Ellis; Paul J Harrison; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2011-01-15       Impact factor: 13.382

2.  Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma.

Authors:  J J Luykx; S C Bakker; W F Visser; N Verhoeven-Duif; J E Buizer-Voskamp; J M den Heijer; M P M Boks; J H Sul; E Eskin; A P Ori; R M Cantor; J Vorstman; E Strengman; J DeYoung; T H Kappen; E Pariama; E P A van Dongen; P Borgdorff; P Bruins; T J de Koning; R S Kahn; R A Ophoff
Journal:  Mol Psychiatry       Date:  2015-02-10       Impact factor: 15.992

3.  Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System.

Authors:  Fernando J Martinez; Gabriel A Pratt; Eric L Van Nostrand; Ranjan Batra; Stephanie C Huelga; Katannya Kapeli; Peter Freese; Seung J Chun; Karen Ling; Chelsea Gelboin-Burkhart; Layla Fijany; Harrison C Wang; Julia K Nussbacher; Sara M Broski; Hong Joo Kim; Rea Lardelli; Balaji Sundararaman; John P Donohue; Ashkan Javaherian; Jens Lykke-Andersen; Steven Finkbeiner; C Frank Bennett; Manuel Ares; Christopher B Burge; J Paul Taylor; Frank Rigo; Gene W Yeo
Journal:  Neuron       Date:  2016-10-20       Impact factor: 17.173

4.  Structural basis for potent inhibition of d-amino acid oxidase by thiophene carboxylic acids.

Authors:  Yusuke Kato; Niyada Hin; Nobuo Maita; Ajit G Thomas; Sumire Kurosawa; Camilo Rojas; Kazuko Yorita; Barbara S Slusher; Kiyoshi Fukui; Takashi Tsukamoto
Journal:  Eur J Med Chem       Date:  2018-09-18       Impact factor: 6.514

Review 5.  Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

Authors:  Joseph T Coyle; Alo Basu; Michael Benneyworth; Darrick Balu; Glenn Konopaske
Journal:  Handb Exp Pharmacol       Date:  2012

6.  A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia.

Authors:  Vinita Jagannath; Miriam Gerstenberg; Christoph U Correll; Susanne Walitza; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

Review 7.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

8.  The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.

Authors:  Sean M Smith; Jason M Uslaner; Peter H Hutson
Journal:  Open Med Chem J       Date:  2010-05-27

Review 9.  The neurobiology of D-amino acid oxidase and its involvement in schizophrenia.

Authors:  L Verrall; P W J Burnet; J F Betts; P J Harrison
Journal:  Mol Psychiatry       Date:  2009-09-29       Impact factor: 15.992

10.  D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO).

Authors:  Pilleriin Sikka; Rosie Walker; Rebecca Cockayne; Matthew J A Wood; Paul J Harrison; Philip W J Burnet
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.